| Application no. and date | 99931229.1 (espacenet) (Federated) (European Patent Register), 19990630 | | Patent/reg. no. and date | DK/EP 1094839, 20030502 | | Publication date | 20010502 | | Priority no. and date | EP 98202257, 19980706, EP 98204330, 19981218 | | EP pub. no. and date |
EP 1094839 20010502 | | Effective date | | | Applicant/owner | JANSSEN PHARMACEUTICA N.V., Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | 1391 | | Inventor | VAN GINCKEL, Robert Franciscus, Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse, BE,
FLOREN, Wim Joanna,
Janssen Pharmaceutica N.V., Turnhoutseweg 30
B-2340 Beerse, BE,
END, David William,
Janssen Research Foundation, Welsh and McKean Roads
Spring House, PA 19477-0776, US,
WOUTERS, Walter Boudewijn Leopold, Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse, BE | | Representative | | | Opponent | | | IPC Class | A61P 35/00, A61K 41/00 | | Title | Farnesylproteintransferaseinhibitorer med in vivo radiosensibiliserende egenskaber | | Int. application no. | EP1999004545 | | Int. publication no. | WO2000001411 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
